In a decidedly vague announcement Tuesday, regenerative medicine company BioTime’s subsidiary LifeMap Sciences said it’s spun off a mobile health company.
LifeMap Solutions will “make health easier to measure and manage” by integrating data from mobile devices with other data like genetic profiles, lifestyle data and electronic records in a cloud-based system, BioTime said.
It’s doing that by working with researchers at the Icahn School of Medicine at Mount Sinai. Specifically, Eric Schadt, the founding director of the school’s Institute for Genomics and Mulitscale Biology, will lend his expertise as the company’s scientific adviser. Mount Sinai’s focus will be on developing a software engine, while LifeMap will develop the entire technology platform, BioTime said.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
CEO Corey Bridges told the San Francisco Business Times that Mount Sinai wasn’t investing money but was allowing the startup to use some of its resources at a significant discount. BioTime, however, did put up a $5 million seed round for the company.
Bridges is the former business development manager at Netflix and ran marketing for James Cameron and Vince Pace’s 3D technology and production company Cameron Pace Group. Co-founder David Warshawsky is also co-founder and CEO of LifeMap Sciences.
LifeMap Solutions is based in Alameda, California.
[Image credit: Flickr user Fettuccinealfredo]
